Literature DB >> 22903849

Severe hepatitis associated with varicella zoster virus infection in a patient with diffuse large B cell lymphoma treated with rituximab-CHOP chemotherapy.

Akinao Okamoto1, Akihiro Abe, Masataka Okamoto, Tsukane Kobayashi, Tomohiko Terazawa, Yoko Inaguma, Masutaka Tokuda, Masamitsu Yanada, Satoko Morishima, Tadaharu Kanie, Yukiya Yamamoto, Motohiro Tsuzuki, Yoshiki Akatsuka, Shuichi Mizuta, Tetsushi Yoshikawa, Nobuhiko Emi.   

Abstract

Severe disseminated varicella zoster virus (VZV) infection rarely occurs in patients who are not recipients of hematopoietic stem cell transplantation. This report concerns severe disseminated VZV infection in a diffuse large B cell lymphoma (DLBCL) patient treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP). The patient was an 82-year-old male with DLBCL who had a history of type II diabetes mellitus. He incurred VZV infection with severe hepatitis and disseminated intravascular coagulopathy after three courses of R-CHOP. When the VZV infection occurred, anti-VZV IgG was not detected and lymphopenia was observed. We initiated treatment with acyclovir, immunoglobulin, and thrombomodulin alpha, and rescued this patient. We suggest that the use of chemotherapy for immune-suppressed elderly lymphoma patients may involve the risk of severe VZV infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22903849     DOI: 10.1007/s12185-012-1160-4

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  24 in total

1.  Molecular diagnosis of visceral herpes zoster.

Authors:  M D de Jong; J F Weel; M H van Oers; R Boom; P M Wertheim-van Dillen
Journal:  Lancet       Date:  2001-06-30       Impact factor: 79.321

2.  Influence of age and nature of primary infection on varicella-zoster virus-specific cell-mediated immune responses.

Authors:  Adriana Weinberg; Ann A Lazar; Gary O Zerbe; Anthony R Hayward; Ivan S F Chan; Rupert Vessey; Jeffrey L Silber; Rob R MacGregor; Kenny Chan; Anne A Gershon; Myron J Levin
Journal:  J Infect Dis       Date:  2010-04-01       Impact factor: 5.226

3.  Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome.

Authors:  Y Koc; K B Miller; D P Schenkein; J Griffith; M Akhtar; J DesJardin; D R Snydman
Journal:  Biol Blood Marrow Transplant       Date:  2000       Impact factor: 5.742

Review 4.  Rituximab-associated infections.

Authors:  Juan C Gea-Banacloche
Journal:  Semin Hematol       Date:  2010-04       Impact factor: 3.851

Review 5.  Varicella.

Authors:  Ulrich Heininger; Jane F Seward
Journal:  Lancet       Date:  2006-10-14       Impact factor: 79.321

Review 6.  Varicella-zoster virus.

Authors:  A M Arvin
Journal:  Clin Microbiol Rev       Date:  1996-07       Impact factor: 26.132

7.  Fulminant hepatic failure due to varicella zoster in a heart transplant patient: successful liver transplant.

Authors:  Marlén Alvite-Canosa; María Jesús Paniagua-Martín; Julia Quintela-Fandiño; Alejandra Otero; María Generosa Crespo-Leiro
Journal:  J Heart Lung Transplant       Date:  2009-09-26       Impact factor: 10.247

Review 8.  Immune responses to varicella-zoster virus.

Authors:  A M Arvin
Journal:  Infect Dis Clin North Am       Date:  1996-09       Impact factor: 5.982

9.  Addition of rituximab to cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy has a high risk of developing interstitial pneumonia in patients with non-Hodgkin lymphoma.

Authors:  Hiroo Katsuya; Junji Suzumiya; Hidenori Sasaki; Kenji Ishitsuka; Takao Shibata; Yasushi Takamatsu; Kazuo Tamura
Journal:  Leuk Lymphoma       Date:  2009-11

10.  Risk of Herpes zoster in patients with underlying diseases: a retrospective hospital-based cohort study.

Authors:  A Hata; M Kuniyoshi; Y Ohkusa
Journal:  Infection       Date:  2011-07-29       Impact factor: 3.553

View more
  1 in total

1.  Disseminated herpes zoster infection initially presenting with abdominal pain in patients with lymphoma undergoing conventional chemotherapy: A report of three cases.

Authors:  Hitomi Sumiyoshi Okuma; Yukio Kobayashi; Shinichi Makita; Hideaki Kitahara; Suguru Fukuhara; Wataru Munakata; Tatsuya Suzuki; Dai Maruyama; Kensei Tobinai
Journal:  Oncol Lett       Date:  2016-06-07       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.